Kohshin Washiyama

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Computed Tomography

Top Venues

Scientific reports

European journal of nuclear medicine and molecular imaging

Molecular pharmaceutics

Fukushima Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fukushima Medical University Oct 1o 2017

Japan

Associate Professor :: Advanced Clinical Research Center

Publications

Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kazuhiro Takahashi, Yoji Kitamura, Hiroshi Wakabayashi, Seigo Kinuya, Kazuma Ogawa
Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 ( 211 At). European journal of nuclear medicine and molecular imaging (2023)
Mitsuyoshi Yoshimoto, Yukie Yoshii, Hiroki Matsumoto, Mitsuhiro Shinada, Masashi Takahashi, Chika Igarashi, Fukiko Hihara, Tomoko Tachibana, Ayano Doi, Tatsuya Higashi, Hirofumi Fujii, Kohshin Washiyama
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy. Pharmaceutics 13 (10) (2021)
Kazuma Ogawa, Hiroaki Echigo, Kenji Mishiro, Saki Hirata, Kohshin Washiyama, Yoji Kitamura, Kazuhiro Takahashi, Kazuhiro Shiba, Seigo Kinuya
68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides. Molecular pharmaceutics 18 (9) (2021)
Noboru Oriuchi, Miho Aoki, Naoyuki Ukon, Kohshin Washiyama, Chengbo Tan, Saki Shimoyama, Ken-Ichi Nishijima, Kazuhiro Takahashi, Hiroshi Ito, Takayuki Ikezoe, Songji Zhao
Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody. Scientific reports 10 (1) (2020)